Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie K Jones

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Molecular Psychiatry|August 18, 2018
Activation of the mGlu<sub>1</sub> metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M<sub>4</sub> muscarinic receptor allosteric modulatorsSamantha E Yohn, Daniel J Foster, Dan P Covey, et al.
Genes, Brain, and Behavior|April 6, 2020
Phenotypic profiling of mGlu<sub>7</sub> knockout mice reveals new implications for neurodevelopmental disordersNicole M Fisher, Robert W Gould, Rocco G Gogliotti, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design and Synthesis of mGlu<sub>2</sub> NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide CoreKatrina A Bollinger, Andrew S Felts, Christopher J Brassard, et al.
ACS Chemical Neuroscience|October 1, 2011
Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous systemEvan P Lebois, Thomas M Bridges, L Michelle Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptorJames M Salovich, Paige N Vinson, Douglas J Sheffler, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Molecular Psychiatry|August 18, 2018
Activation of the mGlu<sub>1</sub> metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M<sub>4</sub> muscarinic receptor allosteric modulatorsSamantha E Yohn, Daniel J Foster, Dan P Covey, et al.
Genes, Brain, and Behavior|April 6, 2020
Phenotypic profiling of mGlu<sub>7</sub> knockout mice reveals new implications for neurodevelopmental disordersNicole M Fisher, Robert W Gould, Rocco G Gogliotti, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design and Synthesis of mGlu<sub>2</sub> NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide CoreKatrina A Bollinger, Andrew S Felts, Christopher J Brassard, et al.
ACS Chemical Neuroscience|October 1, 2011
Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous systemEvan P Lebois, Thomas M Bridges, L Michelle Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptorJames M Salovich, Paige N Vinson, Douglas J Sheffler, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
Pageof 16